The OPTIMUM Trial is a two-arm, multi-centre, randomised controlled trial of superior design comparing the clinical and cost-utility of two PIVC systems (integrated vs non-integrated) to prevent PIVC complications and failure.
The trial is being undertaken at the Queen Elizabeth II Jubilee Hospital (QEII) and the Royal Brisbane and Women's Hospital (RBWH). This trial will recruit 1560 patients in 2017-2018.
This trial is funded by an Investigator Initiated Study grant from BD.
Contact Dr Rachel Walker for more information. email@example.com